Gilead Sciences (GILD) Misses Q1 EPS by 5c; Reiterates Full Year 2017 Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $150.11 -0.52%
Revenue Growth %: -0.4%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -0.4%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $2.23, $0.05 worse than the analyst estimate of $2.28. Revenue for the quarter came in at $6.505 billion versus the consensus estimate of $6.62 billion.
Reiterates Full Year 2017 Guidance
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Investing.com’s stocks of the week
- Corpay agrees to $100M FTC settlement over marketing practices
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
